Clinical Trial: Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Children Growth Hormone Deficiency: A Multicenter, Randomized, Parallel, Dose-control Clinical Trial II

Brief Summary: To evaluate the safety and efficacy of PEG Somatropin Injection (Jintrolong®) in the treatment of short stature due to endogenous growth hormone deficiency (GHD) in the broad of population of children.